Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Galmed Pharmaceuticals Q2 EPS $(0.33) Beats $(0.38) Estimate

Galmed Pharmaceuticals (NASDAQ:GLMD) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.38) by 13.16 percent. This is a 26.92 percent decrease over losses of $(0.26) per share
byBill Haddad
August 5, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Galmed Pharmaceuticals (NASDAQ:GLMD) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.38) by 13.16 percent. This is a 26.92 percent decrease over losses of $(0.26) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Preview: Yellow’s Earnings

By Benzinga Insights
Today, 10:58 PM
Yellow (NASDAQ:YELL) is set to give its latest quarterly earnings report on Wednesday, 2022-02-02. Here's what investors need to know before the announcement. Analysts estimate that Yellow will likely report an Earnings Per Share (EPS) of $-0.12.

YELL